Moreover, SHMT2 was significantly upregulated in lung adenocarcinoma tissues, and associated with advanced stages of lung cancer, suggesting its involvement in tumour aggressiveness and potential as a prognostic marker [205]. Here, SHMT2 is linked to lung carcinoma.